Jan 27, 2026 08:31AM
Jan 27, 2026 08:30AM
Jan 20, 2026 08:30AM
Nov 11, 2025 08:31AM
Nov 11, 2025 08:30AM
Nov 6, 2025 08:30AM
Oct 21, 2025 08:30AM FDA grants orphan drug designation to Quoin's QRX003 for Netherton Syndrome
Oct 21, 2025 08:30AM
Oct 10, 2025 09:25AM
Oct 10, 2025 09:24AM
Aug 7, 2025 08:30AM
Jun 26, 2025 08:30AM
Jun 24, 2025 08:34AM
Jun 24, 2025 08:30AM Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome
May 22, 2025 07:31AM
May 22, 2025 07:30AM
May 13, 2025 08:00AM
Apr 10, 2025 07:30AM
Mar 25, 2025 07:31AM
Mar 25, 2025 07:30AM
Mar 13, 2025 07:30AM Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
Mar 4, 2025 07:30AM
Mar 4, 2025 07:30AM
Feb 4, 2025 07:30AM
Jan 23, 2025 08:30AM
Jan 23, 2025 05:30AM
Jan 14, 2025 08:34AM
Jan 14, 2025 08:30AM Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Jan 7, 2025 02:29PM
Jan 6, 2025 08:33AM
Jan 6, 2025 08:30AM
Dec 19, 2024 08:00AM
Nov 7, 2024 08:00AM
Nov 5, 2024 08:02AM
Nov 5, 2024 08:00AM Quoin Pharmaceuticals Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient
Aug 6, 2024 05:00AM
May 9, 2024 08:30AM
Mar 13, 2024 04:05PM
Mar 4, 2024 08:09AM
Mar 4, 2024 08:02AM
Mar 4, 2024 08:00AM
Feb 14, 2024 09:00AM Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome
Dec 13, 2023 08:30AM
Dec 13, 2023 08:30AM
Aug 17, 2023 08:00AM
Jun 13, 2023 08:00AM
Jun 1, 2023 08:40AM
Mar 8, 2023 05:08PM
Mar 1, 2023 06:40PM A Pivotal Year Ahead for Quoin Pharmaceuticals
Dec 13, 2022 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All